Sponsor:
Weill Medical College of Cornell University
Code:
NCT05085704
Conditions
Glut1 Deficiency Syndrome 1
Glucose Metabolism Disorders
Epilepsy
Glut1 Deficiency Syndrome 1, Autosomal Recessive
Glucose Transporter Type 1 Deficiency Syndrome
Eligibility Criteria
Sex: All
Age: 16 - 70+
Healthy Volunteers: Accepted
Interventions
Magnetic resonance imaging
Brief summary:
Conditions
Glut1 Deficiency Syndrome 1
Glucose Metabolism Disorders
Epilepsy
Glut1 Deficiency Syndrome 1, Autosomal Recessive
Glucose Transporter Type 1 Deficiency Syndrome
Study ID
NCT05085704
Start date
May 3, 2022
Status verified date
May, 2026
Completion date
Aug 1, 2029
Anticipated
Primary completion date
Jun 1, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 16 - 70+
Healthy Volunteers: Accepted
Enrollment
20 participants
Anticipated
Arms
Adolescents and adults with Glut1 deficiency
Normal healthy adolescents and adults
Interventions
Magnetic resonance imaging
Primary outcome measure
Central contacts
Locations
Weill Cornell Medicine
Recruiting
New York, New York, United States, 10065
Contacts
Sponsor
Weill Medical College of Cornell University
Last update posted
Jun 1, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-06-01.